Clinical Trial Update: Proteomic Assessment of Preterm Birth

View source ↗

Summary

A completed clinical trial evaluating proteomic biomarkers for predicting preterm birth, sponsored by Sera Prognostics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Sera Prognostics, Inc. | Conditions: Preterm Birth | Status: COMPLETED